APA (7th ed.) Citation

Giri, S., Tronvik, E., Linde, M., & Hagen, K. (2022). The impact of topiramate, botulinum toxin type A, and CGRP-antibodies on medication overuse headache in patients with chronic migraine: A protocol for systematic review and meta-analysis. Cephalalgia Reports, 5, 1. https://doi.org/10.1177/25158163221096867

Chicago Style (17th ed.) Citation

Giri, Samita, Erling Tronvik, Mattias Linde, and Knut Hagen. "The Impact of Topiramate, Botulinum Toxin Type A, and CGRP-antibodies on Medication Overuse Headache in Patients with Chronic Migraine: A Protocol for Systematic Review and Meta-analysis." Cephalalgia Reports 5 (2022): 1. https://doi.org/10.1177/25158163221096867.

MLA (9th ed.) Citation

Giri, Samita, et al. "The Impact of Topiramate, Botulinum Toxin Type A, and CGRP-antibodies on Medication Overuse Headache in Patients with Chronic Migraine: A Protocol for Systematic Review and Meta-analysis." Cephalalgia Reports, vol. 5, 2022, p. 1, https://doi.org/10.1177/25158163221096867.